David D. Chism
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
Papers in
-
- Renal cell carcinoma treatment 5
-
- Renal and related cancers 4
- Co-authors
- Matthew I. Milowsky (6 shared papers)William Y. Kim (3 shared papers)Joel S. Parker (1 shared paper)Huihui Fan (1 shared paper)Gopa Iyer (1 shared paper)Jeffrey S. Damrauer (1 shared paper)Katherine A. Hoadley (1 shared paper)Jen Jen Yeh (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)The Oncologist (2 papers)JCO Oncology Practice (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
David D. Chism
27 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 554
- Cancer Research 232
- Surgery 681
- Pulmonary and Respiratory Medicine 490
- Immunology 224
Countries citing papers authored by David D. Chism
This map shows the geographic impact of David D. Chism's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Chism with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Chism more than expected).
Fields of papers citing papers by David D. Chism
This network shows the impact of papers produced by David D. Chism. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Chism. The network helps show where David D. Chism may publish in the future.
Co-authors
The 25 scholars most cited alongside David D. Chism, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology Hit paper breakdown → | 2014 | 613 |
| 2 | 2018 | 207 | |
| 3 | 2002 | 149 | |
| 4 | 2019 | 120 | |
| 5 | 2005 | 97 | |
| 6 | Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. | 2004 | 88 |
| 7 | 2004 | 79 | |
| 8 | 2003 | 49 | |
| 9 | 2017 | 32 | |
| 10 | 2002 | 32 | |
| 11 | 2017 | 32 | |
| 12 | 2018 | 29 | |
| 13 | 2018 | 28 | |
| 14 | 2014 | 26 | |
| 15 | 2005 | 22 | |
| 16 | 2004 | 19 | |
| 17 | 2019 | 17 | |
| 18 | 2018 | 13 | |
| 19 | 2023 | 13 | |
| 20 | 2013 | 10 |
About David D. Chism
David D. Chism is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Renal cell carcinoma treatment (5 papers), Urinary and Genital Oncology Studies (4 papers), Renal and related cancers (4 papers), Economic and Financial Impacts of Cancer (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Oncology (554 citations), Cancer Research (232 citations), Surgery (681 citations), Pulmonary and Respiratory Medicine (490 citations) and Immunology (224 citations). David D. Chism has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Matthew I. Milowsky, William Y. Kim, Joel S. Parker, Huihui Fan, Gopa Iyer, Jeffrey S. Damrauer, Katherine A. Hoadley, Jen Jen Yeh, Sara E. Wobker and Stephanie A. Shore. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, JCO Oncology Practice, Proceedings of the National Academy of Sciences and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.